ICD-10 Coding for Myopathy(E74.0, G71.0P, G71.2)
Explore detailed ICD-10 coding guidelines for myopathy, including congenital and drug-induced types. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to Myopathy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G71.2 | Congenital myopathy | Use when genetic or biopsy evidence confirms a congenital myopathy. |
|
| G72.0 | Drug-induced myopathy | Use when myopathy is directly linked to drug exposure, such as statins. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMyopathy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Myopathy.
Omitting drug exposure details in drug-induced myopathy
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials.
Mitigation
Always document the specific drug and its temporal relationship to symptoms.
Using unspecified codes when specific etiology is known
Impact
Reimbursement: May lead to claim denials or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases the accuracy of health data.
Mitigation
Always document and code the specific type of myopathy when possible.
Unspecified myopathy coding
Impact
High risk of audit if unspecified codes are used without supporting documentation.
Mitigation
Use specific codes with detailed clinical documentation.